Culley Brian M

President and CEO

Culley Brian M has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Nov 17, 2026.

On the most recent filing, Culley Brian M is listed as President and CEO at Lineage Cell Therapeutics, Inc. Inside the rolling window, Culley Brian M reported 2 open-market purchases totaling $61K in LCTX and no open-market sales. The largest disclosed transaction in the window is a purchase of 40,500 LCTX shares on Nov 16, 2026, worth $37K.

Companies traded

Other insiders at LCTX

Insider Buying

$61K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
LCTXPurchase$37KNov 17SEC ↗
LCTXPurchase$24KMar 12SEC ↗
Showing 1–2 of 2
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Culley Brian M made?

Culley Brian M has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2025.

Which companies does Culley Brian M trade?

Culley Brian M has filed SEC Form 4 disclosures for 1 company, including LCTX.

When was Culley Brian M's most recent SEC Form 4 filing?

Culley Brian M's most recent SEC Form 4 filing on Tracefour is dated Nov 17, 2026.

What is Culley Brian M's job title?

On the most recent SEC Form 4 filings tracked by Tracefour, Culley Brian M is listed as President and CEO.

What is Culley Brian M's total buy and sell value in the current window?

Inside the rolling retention window, Culley Brian M bought $61K and sold $0 based on SEC Form 4 filings.

What was Culley Brian M's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 40,500 LCTX shares on 2026-11-16, worth $37K, per SEC Form 4 filings.